Anzeige
Mehr »
Login
Mittwoch, 22.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Mit dieser Aktie könntest Du von der Cannabis-Legalisierungswelle profitieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema SAVARA

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
13.05.Savara Inc reports results for the quarter ended in March - Earnings Summary-
09.05.Savara GAAP EPS of -$0.11 misses by $0.011
09.05.Savara Inc - 10-Q, Quarterly Report1
09.05.Savara Reports First Quarter 2024 Financial Results and Provides Business Update68LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the first...
► Artikel lesen
12.04.Savara Inc - 8-K, Current Report1
07.03.Savara Inc - S-8, Securities to be offered to employees in employee benefit plans1
07.03.Savara Inc - 10-K, Annual Report1
07.03.Savara Reports Fourth Quarter/Year-End 2023 Financial Results and Provides Business Update63LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the fourth...
► Artikel lesen
04.03.Piper Sandler raises Savara stock target to $16, maintains overweight4
16.02.Savara Inc - 8-K, Current Report1
15.02.JMP starts Savara at buy, cites market potential for lung disease drug4
15.02.Savara shares rise on new 'Market Outperform' rating from JMP Securities1
25.01.Savara Inc - 8-K, Current Report1
05.01.Savara Inc - 8-K, Current Report2
20.12.23Savara added to Nasdaq Biotechnology Index2